NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Peptide testing

Ordered Retatrutide from EHZ Peptides? Mail in a sample (US only) and let us test it.

Test my supply
+3 more ↓
86%
Finnrick rating
#17 of 419 Retatrutide vendors
32 of 36 classifiable tests passed
customers 4.7★ (23)
methodology · Purity focus
Finnrick analysis · Retatrutide

EHZ Peptides' Retatrutide evidence is strong but no longer clean: two purity misses, a Sep identity failure, and an Oct +49% fill outlier break a long high-purity run. Later clean results are the key trajectory check.

methodology →
vendor intelligence report
Vendor Intelligence Report: EHZ Peptides

EHZ's storefront traces to a verified Google Ads advertiser and a likely California commercial vehicle, while its COA library carries Peptide Mom, Nanjing, and Brown Biology artifacts. The report maps unauthorized-channel checks, document overlays, payment rails, and recourse gaps.

33 pages7 risk factors assessed12 Nov 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
Retatrutideselected
$0.63
86%
36
2
Tirzepatide
$0.50
83%
16
3
GHK-Cu
$0.04
81%
7
4
BPC-157
$0.55
50%
6
5
Cagrilintide
$2.10
50%
3
6
Tesamorelin
$1.55
37%
7
7
HGH
$0.53
-
0
8
Ipamorelin
$0.65
-
0
9
MOTS-c
$0.80
-
0
10
TB-500
$1.15
-
0
11
Wolverine
$0.88
-
0
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%20 Jun 2025: 63%30 Jun 2025: 60%21 Aug 2025: 67%4 Sep 2025: 71%18 Sep 2025: 74%30 Sep 2025: 76%30 Sep 2025: 77%13 Oct 2025: 80%13 Oct 2025: 81%13 Oct 2025: 82%21 Oct 2025: 83%23 Oct 2025: 84%13 Dec 2025: 85%13 Dec 2025: 86%17 Dec 2025: 87%17 Dec 2025: 87%7 Jan 2026: 88%7 Jan 2026: 85%7 Jan 2026: 85%26 Jan 2026: 87%26 Jan 2026: 87%9 Feb 2026: 87%10 Feb 2026: 88%15 Feb 2026: 89%4 Mar 2026: 89%6 Mar 2026: 90%16 Jun 2026: 90%13 Jul 2026: 90%17 Jul 2026: 90%6 Aug 2026: 91%7 Sep 2026: 91%14 Sep 2026: 91%17 Sep 2026: 88%30 Sep 2026: 89%6 Oct 2026: 86%23 Oct 2026: 86%15 Nov 2026: current 86%63%86%86%Jun 25Nov 26
Showing Retatrutide tests only
Peptide testing

Ordered Retatrutide from EHZ Peptides? Mail in a sample (US only) and let us test it.

Test my supply
EHZ Peptides Retatrutide test history
COA-backed lab tests
1-10 of 36

About EHZ Peptides test results from Finnrick

EHZ Peptides is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 6 peptides and 75 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible EHZ Peptides peptides in this dataset are BPC-157 (6 tests), Cagrilintide (3 tests) and GHK-Cu (7 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 75 recent tests.

Corrections
No corrections.
Peptide testing

Ordered Retatrutide from EHZ Peptides? Mail in a sample (US only) and let us test it.

Test my supply